ATE480247T1 - Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium - Google Patents

Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium

Info

Publication number
ATE480247T1
ATE480247T1 AT02727769T AT02727769T ATE480247T1 AT E480247 T1 ATE480247 T1 AT E480247T1 AT 02727769 T AT02727769 T AT 02727769T AT 02727769 T AT02727769 T AT 02727769T AT E480247 T1 ATE480247 T1 AT E480247T1
Authority
AT
Austria
Prior art keywords
biomass
strain
immuno
agent containing
methanotrophic bacteria
Prior art date
Application number
AT02727769T
Other languages
English (en)
Inventor
Lars Jorgensen
Arild Johannessen
Karen Moller Jensen
Gunnar Kleppe
Original Assignee
Statoil Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statoil Asa filed Critical Statoil Asa
Application granted granted Critical
Publication of ATE480247T1 publication Critical patent/ATE480247T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Sustainable Development (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
AT02727769T 2002-02-28 2002-05-31 Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium ATE480247T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0204722.3A GB0204722D0 (en) 2002-02-28 2002-02-28 Method
PCT/GB2002/002555 WO2003072133A2 (en) 2002-02-28 2002-05-31 Immunostimulatory agent comprising a biomass of methanotrophic bacterium

Publications (1)

Publication Number Publication Date
ATE480247T1 true ATE480247T1 (de) 2010-09-15

Family

ID=9931987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02727769T ATE480247T1 (de) 2002-02-28 2002-05-31 Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium

Country Status (10)

Country Link
US (1) US20050163802A1 (de)
EP (1) EP1478376B1 (de)
CN (1) CN1622815B (de)
AT (1) ATE480247T1 (de)
AU (1) AU2002257966A1 (de)
CA (1) CA2477371C (de)
DE (1) DE60237645D1 (de)
GB (1) GB0204722D0 (de)
NO (1) NO332176B1 (de)
WO (1) WO2003072133A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7207982B2 (en) 2003-03-31 2007-04-24 Alza Corporation Osmotic pump with means for dissipating internal pressure
GB0315783D0 (en) * 2003-07-04 2003-08-13 Norferm Da Use
NO323529B1 (no) * 2004-05-13 2007-06-04 Trouw Internat Bv Framgangsmate for reduksjon av innholdet av uonskede naeringsstoffer i avlopsvann fra fiskeoppdrettsanlegg.
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP2020990B1 (de) 2006-05-30 2010-09-22 Intarcia Therapeutics, Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
RU2440771C1 (ru) * 2007-12-21 2012-01-27 Хилл'С Пет Ньютришн, Инк. Состав кормового продукта для домашних животных (варианты)
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
NO333891B1 (no) * 2009-01-28 2013-10-14 Trouw Internat Bv Fiskefôr med forhøyet innhold av arginin og framgangsmåte for å forhindre redusert tilvekst for anadrom fisk ved utsett til sjø ved å anvende et slikt fôr
EP2427200B1 (de) * 2009-05-08 2014-04-30 Bioprotein AS Futterzusammensetzung zur behandlung oder prävention von enteritis bei fischen
EP3323423B1 (de) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
DK2872641T3 (en) 2012-07-13 2018-06-14 Calysta Inc BIORAFFINADERY SYSTEM, PROCEDURES AND COMPOSITIONS THEREOF
DK2917358T3 (da) 2012-11-09 2019-09-30 Calysta Inc Sammensætninger og fremgangsmåder til biologisk fremstilling af fedtsyrederivater
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
WO2018204792A2 (en) * 2017-05-05 2018-11-08 White Dog Labs, Inc. Single cell protein products and an integrated method for the production of ethanol and single cell protein
US10883123B2 (en) 2017-06-09 2021-01-05 White Dog Labs, Inc. Integrated wet-mill method for the production of ethanol and single cell protein
GB201712459D0 (en) 2017-08-02 2017-09-13 Norges Miljø-Og Biovitenskapelige Univ Treatment or prevention of gastrointestinal dysbiosis
EP4683889A2 (de) * 2023-03-21 2026-01-28 Windfall Bio, Inc. Bakterielle zusammensetzungen zum verbrauch von methan und zur fixierung von stickstoff

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314820A (en) * 1987-11-13 1994-05-24 Kuwait Institute For Scientific Research Process and microorganisms for producing single cell protein
EP0640348A1 (de) * 1993-07-26 1995-03-01 Akzo Nobel N.V. Adjuvansmischung auf Ölbasis und auf Wasserbasis
GB0003620D0 (en) * 2000-02-16 2000-04-05 Norferm Da Method
GB0120047D0 (en) * 2001-08-16 2001-10-10 Norferm Da Product

Also Published As

Publication number Publication date
DE60237645D1 (de) 2010-10-21
WO2003072133A3 (en) 2003-11-20
AU2002257966A8 (en) 2003-09-09
NO20043741L (no) 2004-09-07
CN1622815B (zh) 2012-08-22
NO332176B1 (no) 2012-07-16
US20050163802A1 (en) 2005-07-28
CA2477371C (en) 2012-07-10
AU2002257966A1 (en) 2003-09-09
GB0204722D0 (en) 2002-04-17
EP1478376A2 (de) 2004-11-24
CN1622815A (zh) 2005-06-01
CA2477371A1 (en) 2003-09-04
WO2003072133A2 (en) 2003-09-04
EP1478376B1 (de) 2010-09-08

Similar Documents

Publication Publication Date Title
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
Larsen et al. Characterization of Bacillus spp. strains for use as probiotic additives in pig feed
Zhang et al. The severity of motile Aeromonas septicemia caused by virulent Aeromonas hydrophila in channel catfish is influenced by nutrients and microbes in water
Jaffar et al. Mature biofilm degradation by potential probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp.
CN103502434B (zh) 乳酸菌以及含有该乳酸菌的组合物
DE60205646D1 (de) Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon
Wang et al. Probiotic and safety properties screening of Enterococcus faecalis from healthy Chinese infants
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
PE20010829A1 (es) Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas
BRPI0417826A (pt) bifidobactéria pseudolongum probiótica canina
DE60316772D1 (de) Von menschen oder tieren verwenbare diätetische und/oder pharmazeutische zubereitungen, auf basis von probiotischen mikroorganismen
AR047066A1 (es) Metodos para usar lactobacilos probioticos para animales de compania
DE69930944D1 (de) Bacillus coagulans-zusammensetzung und deren verwendung
Duan et al. Fine‐tuned production of hydrogen peroxide promotes biofilm formation of Streptococcus parasanguinis by a pathogenic cohabitant Aggregatibacter actinomycetemcomitans
BRPI1006135A2 (pt) Bactérias do ácido láctico e seu uso em produtos microbianos para ração direta a suínos
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
Zhou et al. Probiotic potential analysis and safety evaluation of Enterococcus durans A8-1 isolated from a healthy Chinese infant
US20180344783A1 (en) Natural intra-vaginal inserts to control imbalanced ph
Xie et al. Comparative evaluation of spores and vegetative forms of Bacillus subtilis and bacillus licheniformis on probiotic functionality In vitro and In vivo
MX2024000520A (es) Uso de cepas bacterianas de lactobacillus paracasei en el tratamiento de recien nacidos.
NO20045022L (no) Produkt
Kıray Antibiofilm and anti-quorum sensing activities of vaginal origin probiotics
EP4233912A3 (de) Zusammensetzungen zur verwendung als prophylaktisches mittel gegen infektionsrisiko von tuberkulose oder als sekundäre wirkstoffe zur behandlung von infizierten tuberkulosepatienten
Laomongkholchaisri et al. Impact of potential probiotic Lactobacillus strains on host growth and development in a Drosophila melanogaster model
Andino et al. Characterization and specificity of probiotics to prevent salmonella infection in mice

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties